Risilience is a biomanufacturing Contract Development and Manufacturing Organization (CDMO) founded in 2020. The company focuses on enhancing access to complex medicines, including biologics, vaccines, nucleic acids, cell therapies, and gene therapies. Established in response to challenges in global biopharmaceutical supply chains highlighted by the COVID-19 pandemic, Risilience aims to create a resilient and sustainable manufacturing network for the rapid and safe production of advanced medicines.Headquartered in North America, Risilience operates facilities across the United States and Canada, serving clients globally. The company offers a comprehensive suite of biomanufacturing services, including drug substance and product manufacturing, process development, regulatory expertise, and flexible manufacturing capacity. With a strong emphasis on advanced digital capabilities, Risilience utilizes cloud-based systems and artificial intelligence to enhance manufacturing processes. Led by Founder and CEO Rahul Singhvi, the company is dedicated to supporting pharmaceutical and biotech firms of all sizes in bringing innovative therapies to market efficiently.
7 Reviews
0 Reviews
Not Rated.
Write the first review
Help other software buyers make informed decisions.
It looks like Risilience hasn’t been reviewed yet. If you are a customer of theirs or have used their services in the past, why don’t you be the first to leave a review and tell other visitors about your experience?
Signing in with LinkedIn shows that your review is genuine and written by a real person. We can't and wouldn't post anything to your LinkedIn account or to your connections.
Don't use LinkedIn? You can write unverified reviews too.
Thanks for writing a review, please allow 48 hours for it to appear on the site.